Influenza Activity — United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine

Authors:
  • LBLynnette Brammer
    Lynnette Brammer
  • KKKrista Kniss
    Krista Kniss
  • SEScott Epperson
    Scott Epperson
  • LBLenee Blanton
    Lenee Blanton
  • DMDesiree Mustaquim
    Desiree Mustaquim
  • CSCraig Steffens
    Craig Steffens
  • TDTiffany D’Mello
    Tiffany D’Mello
  • APAlejandro Perez
    Alejandro Perez
  • RDRosaline Dhara
    Rosaline Dhara
  • SCSandra S. Chaves
    Sandra S. Chaves
  • AEAnwar Abd Elal
    Anwar Abd Elal
  • LGLarisa Gubareva
    Larisa Gubareva

Abstract
During the 2012-13 influenza season in the United States, influenza activity* increased through November and December before peaking in late December. Influenza A (H3N2) viruses predominated overall, but influenza B viruses and, to a lesser extent, influenza A (H1N1)pdm09 (pH1N1) viruses also were reported in the United States. This influenza season was moderately severe, with a higher percentage of outpatient visits for influenza-like illness (ILI), higher rates of hospitalization, and more reported deaths attributed to pneumonia and influenza compared with recent years. This report summarizes influenza activity in the United States during the 2012-13 influenza season (September 30, 2012-May 18, 2013) as of June 7, 2013, and reports the recommendations for the components of the 2013-14 Northern Hemisphere influenza vaccine.